Invenia ABUS 2.0

Use remarkable image quality, the coronal view, and advanced interpretation tools to look differently at dense breast tissue for adjunctive screening and diagnostic exams.

 
  • Innovative breast cancer screening

  • Improve breast cancer detection

    Download Brochure
  • Why is Invenia ABUS 2.0 screening needed?

    Download the Sheet
  • What are the steps in an Invenia ABUS 2.0 exam?

Evidence shows mammography ultrasounds aren't always reliable

Invenia ABUS 2.0 can improve early detection

Clinical impact

Discover real-world outcomes and its clinical impact -- from the effectiveness of breast screening to improved cancer detection and economic outcomes.

Economic impact

Webinars

These complimentary webinars feature experienced ABUS users who discuss ABUS in clinical practice.
Testimonials

What are clinicians and patients saying about their experience with ABUS?

From clinicians to patients, ABUS users discuss the clinical need for supplemental screening for dense breasts and how ABUS has performed in clinical practice. Patients and clinicians alike provide their impressions of ABUS supplemental screening for dense breasts and how it has benefited them. For more information on breast care for patients, please visit knowyourrisk.gehealthcare.com
  • Technology designed for screening

To learn more about cleaning GE Healthcare ultrasound products, visit these resources:

For specific information, refer to the product user manual or use this link.
For select products, the user manual may be available on board the system.
For more information about cleaning your scanner, visit the GE Healthcare Cleaning Compatibility Website.
To find cleaning and disinfection information for transducers, visit this web page.
Watch an informational video from Jeff Hersh, M.D., Chief Medical Officer of GE Healthcare on using ultrasound in a health crisis.
Tricefy™ inside your Voluson and ViewPoint™ is offering a free COVID-19 collaboration package for 90 days to healthcare providers globally.
Learn more

Resources

Reimbursement

1. Mandelson et al. J Natl Cancer Inst 2000; 92:1081–1087.
2. Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.
3. Brem et al, Radiology, March 2015.
4. Pisano et al. NEJM 2005; 353: 1773.
5. Engmann NJ, et al, JAMA Oncol. 2017;3(9):1228-1236
6. Boyd NF et al. Mammographic Density and the Risk and Detection of Breast Cancer. NEJM 2007; 356: 227-36.
7. Arora N, King TA, Jacks LM., Ann Surg Onc, 2010; 17:S211-18.